Robert J. Glynn, Sc.D., Ph.D., is a Professor of Medicine (Biostatistics) at Harvard Medical School, where he divides his time between the Divisions of Preventive Medicine and Pharmacoepidemiology and Pharmacoeconomics. He also teaches at the Harvard School of Public Health where he is an Associate Professor of Biostatistics. For over 30 years, his work has focused on the design and analysis of studies of risk factors and treatments for common chronic diseases in older people. Dr. Glynn has designed, monitored, and analyzed data from large-scale randomized trials, prospective cohort studies and case-control studies. His methodological interests include methods for missing data, analysis of clustered data, competing risks, and approaches to identify and adjust for selection bias. He is currently principal investigator of studies on the epidemiology of venous thromboembolism, factors influencing drug choice in older people, and independent monitoring of the ongoing JUPITER Trial. Dr. Glynn has served on numerous data monitoring boards and is the author of over 300 peer-reviewed, original papers.
